Eric S. Rosenthal, MD, serves as Associate Director of the Neurosciences Intensive Care Unit at Massachusetts General Hospital, where he directs the Neurocritical Care Fellowship Training Program and the MGH Critical Care Neuromonitoring Program.
Dr. Rosenthal devotes clinical time in the MGH Neurosciences ICU, on the MGH Acute Stroke Service, as part of the MGH Telestroke Service, and as part of the Epilepsy Service. His clinical interests include traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), acute stroke, intracerebral hemorrhage, and seizure disorders in critically ill patients, including status epilepticus.
Dr. Rosenthal performs clinical research on innovative approaches that individualize patient care by integrating existing neuromonitoring tools with novel noninvasive methods such as quantitative electroencephalography (EEG), electrical impedance spectroscopy (EIS), and Near-Infrared Spectroscopy (NIRS) optical monitoring.
Dr. Rosenthal graduated from Harvard Medical School, the Harvard/Partners Neurology Residency Training Program, and the MGH/BWH/Harvard Neurocritical Care Fellowship Training Program.
Massachusetts General Hospital investigators collaborate with clinical staff to generate new knowledge and discuss innovations at the First Annual Critical Care Research Retreat.
Q + A with Eric Rosenthal, MD about ESETT, a new treatment trial for patients with severe seizures
Members of the Massachusetts General Hospital Critical Care Center and the Department of Anesthesia, Critical Care and Pain Medicine discuss continuous brain monitoring in critical care.
Phone 2: 857-238-5654